Fady Nasr

Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study

Aline Hajj, Roula El Hachem, Rita Khoury et al. · BMC Cancer · 2021 · 53 citations · Full text

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

Vincent Ribrag, Fady Nasr, JH Bouhris et al. · Bone Marrow Transplantation · 1998 · 35 citations

Oncology, Pathology, Therapeutic Efficacy +5

Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer

Fady Nasr, G. Chahine, Joseph Kattan et al. · Clinical Breast Cancer · 2004 · 34 citations

Second-line Treatment, Carboplatin Combination Therapy, Breast Oncology +7

Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC)

Joseph Kattan, F. Farhat, Georges Y. Chahine et al. · Investigational New Drugs · 2007 · 16 citations

Zoledronic Acid, Urology, Medicine +8

Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the “CAGE-Cog” study

Aline Hajj, Rita Khoury, Roula El Hachem et al. · BMC Cancer · 2022 · 15 citations · Full text